We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$590M
Cap. Flow
+$155M
Cap. Flow %
2.79%
Top 10 Hldgs %
22.88%
Holding
313
New
33
Increased
112
Reduced
69
Closed
58

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$94.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$94.1M
3
MSFT icon
Microsoft
MSFT
+$43.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$35.6M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$34.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$77.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$58.9M
3
WFC icon
Wells Fargo
WFC
+$36.6M
4
WBA
Walgreens Boots Alliance
WBA
+$32.1M
5
CMCSA icon
Comcast
CMCSA
+$31.3M

Sector Composition

Rank Sector Weight
1 Healthcare 24.54%
2 Technology 23.84%
3 Financials 21.07%
4 Communication Services 10.37%
5 Consumer Discretionary 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFG icon
226
Citizens Financial Group
CFG
$30.8B
$754K 0.01%
+28,780
New +$725K
RDUS
227
DELISTED
Radius Health, Inc.
RDUS
$573K 0.01%
9,309
-8,743
-48% -$552K
LAB icon
228
Standard BioTools
LAB
$311M
$548K 0.01%
50,717
+26,622
+110% +$261K
IONS icon
229
Ionis Pharmaceuticals
IONS
$9.14B
$540K 0.01%
+8,727
New +$471K
HALO icon
230
Halozyme
HALO
$9.9B
$531K 0.01%
+30,649
New +$489K
ACAD icon
231
Acadia Pharmaceuticals
ACAD
$4.45B
$520K 0.01%
14,595
-6,738
-32% -$237K
SIVB
232
DELISTED
SVB Financial Group
SIVB
$485K 0.01%
4,076
+302
+8% +$37.5K
HSTO
233
DELISTED
Histogen Inc. Common Stock
HSTO
$446K 0.01%
783
– –
SC
234
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$418K 0.01%
+26,348
New +$482K
PB icon
235
Prosperity Bancshares
PB
$8.82B
$416K 0.01%
8,682
+410
+5% +$21.1K
VTAE
236
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$409K 0.01%
22,608
+3,597
+19% +$49.5K
ALKS icon
237
Alkermes
ALKS
$8.42B
$361K 0.01%
4,547
-2,587
-36% -$181K
TBRA
238
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$342K 0.01%
34,061
-33,509
-50% -$348K
LXRX icon
239
Lexicon Pharmaceuticals
LXRX
$1.04B
$333K 0.01%
+25,000
New +$307K
OCUL icon
240
Ocular Therapeutix
OCUL
$1.85B
$328K 0.01%
+35,000
New +$378K
QIWI
241
DELISTED
QIWI PLC
QIWI
$311K 0.01%
17,317
– –
CWEN.A
242
DELISTED
Clearway Energy Class A
CWEN.A
$283K 0.01%
+20,342
New +$277K
LSAK icon
243
Lesaka Technologies
LSAK
$392M
$265K ﹤0.01%
19,593
+5,300
+37% +$83.1K
PRQR icon
244
ProQR Therapeutics
PRQR
$248M
$260K ﹤0.01%
30,000
-5,000
-14% -$57.5K
WT icon
245
WisdomTree
WT
$2.97B
$234K ﹤0.01%
14,950
– –
VRML
246
DELISTED
Vermillion, Inc.
VRML
$180K ﹤0.01%
100,000
+73,537
+278% +$142K
NBRV
247
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$104K ﹤0.01%
+44
New +$107K
ADI icon
248
Analog Devices
ADI
$178B
– –
-101,647
Closed -$5.73M
AFMD
249
DELISTED
Affimed
AFMD
– –
-4,355
Closed -$269K
AVAV icon
250
AeroVironment
AVAV
$7.91B
– –
-83,350
Closed -$1.67M
8 9
10
11 12

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Polar Capital held 313 positions worth $5.53B, up 12% from $4.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital's Q4 2015 filing shows 33 new, 112 increased, 69 reduced and 58 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,541,420 shares worth $98.9M. The largest sale was Pfizer, an estimated $77.3M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

  • Polar Capital's largest Q4 2015 buy was Alphabet (Google) Class A: 2,541,420 shares worth $98.9M.
  • Polar Capital added most to Johnson & Johnson in Q4 2015, an estimated $94.4M increase.
  • Polar Capital's biggest Q4 2015 reduction was Pfizer, cutting an estimated $77.3M.
  • Polar Capital fully exited Walgreens Boots Alliance in Q4 2015, selling an estimated $32.1M.
  • Polar Capital's ten largest holdings make up 23% of its $5.53B portfolio in Q4 2015.
  • Polar Capital opened 33 new positions and closed 58 in Q4 2015.
  • Polar Capital's portfolio value rose 12% quarter-over-quarter to $5.53B.

Based on Polar Capital's 13F filing for Q4 2015, filed 16 Feb 2016.